Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Cash & Current Investments came in at $143.0 million in Q1 2026, up 39.92% year-on-year from $102.2 million in Q1 2025, and down 13.14% on a QoQ basis from $164.6 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash & Current Investments (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Cash & Current Investments data on file, last reported at $143.0 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 39.92% year-over-year to $143.0 million in Q1 2026; TTM through Mar 2026 was $143.0 million, a 39.92% increase from a year earlier, with the FY2025 full-year figure at $164.6 million, up 54.63% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $143.0 million, down from $164.6 million in the prior quarter.
- Over the last five years, Cash & Current Investments for STVN reached as high as $443.7 million in Q1 2022 and fell as low as $72.3 million in Q2 2023.
- Historically, Cash & Current Investments has averaged $173.7 million across 5 years, with a median of $141.6 million in 2025.
- Across the five-year window, Cash & Current Investments jumped 138.03% in 2022 and sank 80.41% in 2023, its largest moves.
- Year by year, Cash & Current Investments stood at $267.7 million in 2022, then plunged by 70.25% to $79.6 million in 2023, then surged by 33.67% to $106.4 million in 2024, then surged by 54.63% to $164.6 million in 2025, then decreased by 13.14% to $143.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $143.0 million in Q1 2026, $164.6 million in Q4 2025, and $141.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Stevanato Group S.p.A | 5.39 Bn | 5.25 Bn | 88.01 Mn | 142.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 142.95 Mn |
| Dec 31, 2025 | 164.57 Mn |
| Sep 30, 2025 | 141.56 Mn |
| Jun 30, 2025 | 120.76 Mn |
| Mar 31, 2025 | 102.16 Mn |
| Dec 31, 2024 | 106.43 Mn |
| Sep 30, 2024 | 88.56 Mn |
| Jun 30, 2024 | 86.65 Mn |
| Mar 31, 2024 | 206.04 Mn |
| Dec 31, 2023 | 79.62 Mn |
| Sep 30, 2023 | 73.18 Mn |
| Jun 30, 2023 | 72.26 Mn |
| Mar 31, 2023 | 191.93 Mn |
| Dec 31, 2022 | 267.65 Mn |
| Sep 30, 2022 | 295.78 Mn |
| Jun 30, 2022 | 368.95 Mn |
| Mar 31, 2022 | 443.70 Mn |
| Dec 31, 2021 | 501.33 Mn |
| Sep 30, 2021 | 537.07 Mn |
| Jun 30, 2021 | 155.00 Mn |